Medesis Pharma SA - Company Review
SummaryMedesis Pharma SA - Company Review
Summary
Medesis Pharma SA (Medesis) is a therapeutic agents developer. The company's product pipeline includes NP01, a product based on vanadium; and NP03, a product based on aonys formulation of lithium citrate for the treatment of Huntington’s disease. Medesis is also developing novel decorporation drugs such as NU01, a plutonium decorporation; NU02, a uranium decorporation and NU03, a caesium decorporation to eliminate toxic metals. The company uses its proprietary drug delivery technology Aonys for the development of its products. It operates in therapeutic agents such as pharmacologically active metals, RNA, microRNA and antisense oligonucleotides. The company operates through research laboratories, and medical institutes. It operations in France and Canada. Medesis is headquartered in Baillargues, France.
This comprehensive company report of Medesis Pharma SA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.